Why are digital therapeutic companies not connecting to the traditional healthcare system by integrating with an EMR.
Currently, the world of the traditional EMR system and the world of digital therapeutic companies (DTx) do not integrate, and the reason is that there are significant barriers preventing integration. There are four main barriers today that prevent further integration. A new approach is needed. When looking at EMR integration, there are two worlds. On Learn more...
How covid-19 took the global digital health industry by surprise
Around the world, the digital health industry largely underestimated the positive impact that the COVID-19 pandemic would have on their business. R2G released a new survey summarizing these impacts, and other changes in the industry since the beginning of the pandemic. The COVID-19 pandemic has impacted lives, societies, and economies around the world. Seemingly overnight, Learn more...
DiGA listing is not enough! Finding the right channel to reach doctors and patients in Germany
The DiGA Fast Track provides both a reimbursement model and quality stamp for digital health solutions looking to enter the German market. However, download rates of recently approved solutions show that listing as DiGA alone does not ensure a high adoption rate. Companies will therefore have to develop a comprehensive market entry strategy and select Learn more...
How Happify Health supports the mental and physical health of 20 million people with DTx & patient care solutions. Interview with Christopher Wasden, Head of Happify DTx.
The pandemic has enormously increased the demand for access to personalized mental health services and brought digital mental health solutions and digital therapeutics programs to the frontline of global health investments. Millions of dollars were invested in innovative digital health providers to scale mental health care delivery and chronic disease management programs to improve population Learn more...
Four main reasons of why digital biomarkers are hot
Digital biomarkers are becoming a hot topic. Investors are lining up. Pharma companies are eager to secure the best digital biomarker development companies to support their clinical and commercial initiatives. But what makes the digital biomarkers so attractive? There are four reasons of why digital biomarkers are getting the attention of the investors. Until the Learn more...
Opportunities and Challenges in the German Digital Health Market
The DiGA Fast Track has brought the German market to the attention of foreign media, digital service providers, and healthcare investors alike. Germany’s large health system has long been attractive for investment, yet rigid bureaucracy prevented significant growth. DiGA presents, finally, an opportunity for digital innovation. Yet, this approval can only be one small part Learn more...
R2G launches a new global survey: 2021 Global COVID-19 Survey – What has changed in the digital health industry after one year of pandemic?
R2G launches a new global covid-19 2021 survey to assess the impact covid-19 has had on the digital health industry. R2G conducted a global survey at the beginning of the pandemic in 2020 to understand the views and opinions the digital health experts had on the impact of covid-19 on the digital health industry. This Learn more...
Keeping Up with Tech: How can digital health start-ups compete with the rise of consumer wellness solutions?
As Apple, Google, and other tech giants expand their services, access to high quality, personal health data becomes more accessible for the average consumer. But what happens to the digital health start-ups operating in this space? We’ll take a look at examples in two popular subsegments- women’s health and cardiovascular health- to see how successful Learn more...
How Glooko improves health outcomes by connecting people with diabetes and obesity and their healthcare professionals, enabling telehealth, clinical research, and better collaboration! Interview with Zach Henderson, Chief Commercial Officer at Glooko.
The pandemic positioned Telehealth and Remote Patient Monitoring solutions as a key element of healthcare services to drive quality population health outcomes and reduce care costs. With rules and regulations rapidly changed to enable the coverage of these solutions, over 217m diagnosed diabetics with access to smart devices and 1.5b overweight people globally could potentially Learn more...